Olema Pharmaceuticals Inc (OLMA) Insider Trading
- $53,844,919.13
- $48,913,124.99
- Dec. 17, 2024
- Cyrus Harmon
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 10, 2021 | Insider | 5,251 | $29.72 | Sell | $156,059.72 | |
| May 18, 2021 | Insider | 57,763 | $24.15 | Sell | $1,394,976.45 | |
| Nov. 23, 2020 | Director | 1,160,000 | $19.00 | Buy | $22,040,000.00 | |
| Nov. 23, 2020 | Major Shareholder | 425,000 | $19.00 | Buy | $8,075,000.00 |
Insiders are both buying and selling Olema Pharmaceuticals Inc stock.
The insider traders at Olema Pharmaceuticals Inc are: Cyrus Harmon, Kinney Horn, Sean Bohen, David C Myles, Bvf Partners L P/Il, Biocapital Advisors L Paradigm, G. Walmsley Graham, Naseem Zojwalla, and Cormorant Asset Management, Lp
The most active insider trader at Olema Pharmaceuticals Inc is Cyrus Harmon with 26 trades.
Biocapital Advisors L Paradigm has sold the most Olema Pharmaceuticals Inc stock with a total value of $71,568,000.00.
G. Walmsley Graham has bought the most Olema Pharmaceuticals Inc stock with a total value of $44,080,000.00.
The most recent insider trade for Olema Pharmaceuticals Inc was on Dec. 17, 2024.
The single biggest insider buy for Olema Pharmaceuticals Inc was from G. Walmsley Graham with a total value of $22,040,000.00 on Nov. 23, 2020.
The single biggest insider sell for Olema Pharmaceuticals Inc was from Biocapital Advisors L Paradigm with a total value of $35,784,000.00 on Aug. 1, 2024.